The technologies that have been developed to combat COVID have opened a new chapter for the development of drugs with high specificity, those that will allow us to get to...
Jose Luis Pérez director of Trece al día interviews the Spanish doctor and scientist Dr. Javier Pérez, director of the intensive care unit at Baptista Hospital in Miami, in charge of directing the testing phase of the drug Zyesami from NRX Pharmaceuticals...
Miguel Ángel Temprano participates one more Monday in the Business TV gathering directed by the journalist Fernando Latienda in his program Ponte en Acción. Today the gathering is about the impact of the gas shortage on the markets, as well as the impact it is...
A new technology, that based on mRNA, has shown that more effective and easily modifiable vaccines can be obtained. An uninteresting business, as it was the manufacture of vaccines has become...
Miguel Ángel Temprano, CEO of Orfeo Capital, intervenes in the Trece Tv News program to satisfy the change in government forecasts regarding GDP growth according to previous INE estimates...
Miguel Ángel Temprano, CEO of Orfeo Capital is interviewed this time by the journalist Marta Iser in the "evening program" of Negocios TV, Rolling Stocks, to analyze the problem of EVERGRANDE, this time from the perspective of the company itself. Miguel Ángel analyzes the influence...
Miguel Ángel Temprano, CEO of Orfeo Capital, took part in the morning program of Negocios TV Business connection directed by Jose Antonio Vizner, to analyze in depth the problem created by the probable non-payment of the upcoming maturities of Evergrande's debt. Miguel Ángel analyzes the...
One more Monday, Miguel Ángel Temprano, CEO of Orfeo Capital participates in the gathering of the Business TV program Get in action, directed by Fernando Latienda where the crisis generated by the announcement of the Chinese company Evergrande of the probable non-payment of the next...